机构名称：
¥ 1.0
We look forward to engaging in open and transparent conversations with CMS, where we will share information on the value that XIFAXAN® delivers for the healthcare system in addition to sharing recommendations from The American Association for the Study of Liver Diseases (AASLD) and the European Association for the Study of the Liver (EASL) who gave XIFAXAN® the highest possible recommendation (Grade I, A,1) via their practice guidelines.我们将继续受到对患者的承诺，倡导支持患者获得关键药物的医疗保健环境，并鼓励未来的创新。关于xifaxan指示xifaxan®（利法西明蛋白）550毫克片剂用于降低成人成人明显的肝性脑病（HE）复发的风险，并治疗成人腹泻（IBS-D）的肠易激综合症。重要的安全信息
Bausch Health Saters on Selections ofXifaxan®（...
主要关键词
相关文件推荐
